Xeljanz (tofacitinib) is an immunomodulator used to treat adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It is taken orally as a tablet once or twice daily. Common side effects include diarrhea, headache, respiratory tract infections, the Show Full Answer

Xeljanz (tofacitinib) is an immunomodulator used to treat adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It is taken orally as a tablet once or twice daily. Common side effects include diarrhea, headache, respiratory tract infections, the common cold, and urinary tract infections. There are also rare but serious side effects, including cardiovascular events and cancer risks, especially at higher doses. Always consult your healthcare provider before making any changes to your medication.

 This AI-generated response comes from myRAteam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Xeljanz Study Raises Some Concerns About Heart and Cancer Risks: What Patients Need to Know

Xeljanz (Tofacitinib) for Rheumatoid Arthritis | myRAteam